[Endothelial dysfunction. Therapeutic and prognostic issues].
Kelm
M
M
Medizinische Klinik, Heinrich-Heine-Universität Düsseldorf.
Strauer
B E
BE
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D001120:Arginine / Q000378:metabolism; D016228:Endothelial Growth Factors / Q000378:metabolism; D004730:Endothelium, Vascular / Q000378:metabolism* / Q000503:physiopathology; D015914:Estrogen Replacement Therapy; D015444:Exercise; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D009569:Nitric Oxide / Q000378:metabolism; D011379:Prognosis; D016540:Smoking Cessation; D014652:Vascular Diseases / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology* / Q000628:therapy*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000975:Antioxidants; D016228:Endothelial Growth Factors; D005343:Fibrinolytic Agents; D000960:Hypolipidemic Agents; D009569:Nitric Oxide; D001120:Arginine